Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows.
BioLight Announces A Joint Cooperation Agreement With Alexion To Explore An Innovative Technology Based On Natural Tears For The Diagnosis Of Retinal Diseases
BioLight (TASE: BOLT) is proud to report it has signed a research collaboration agreement with Alexion (AstraZeneca Rare Disease), focusing on exploring a groundbreaking technology that utilizes natural tears
Benzinga’s Top Ratings Upgrades, Downgrades For May 12, 2023
Upgrades According to SVB Leerink, the prior rating for Bolt Biotherapeutics Inc (NASDAQ:BOLT) was changed from Market Perform…
Bolt Biotherapeutics To Present Clinical Data From Phase 1 Dose-Escalation Trial Of BDC-1001 in HER2-Expressing Tumors At 2023 ASCO Annual Meeting
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT), a clinical-stage biopharmaceutical company pioneering novel immuno-oncology therapeutics for the treatment of cancer, today announced that it will present a poster with clinical
Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies
Bolt Biotherapeutics Inc (NASDAQ:BOLT) reported topline data from the dose-escalation study of BDC-1001 in HER2-expressing solid tumors that support advancing into…
Looking Into Bolt Biotherapeutics’s Return On Capital Employed
According to Benzinga Pro data, during Q4, Bolt Biotherapeutics (NASDAQ:BOLT) posted sales of $1.41 million. Earnings were up…
Looking Into Bolt Biotherapeutics’s Return On Capital Employed
According to Benzinga Pro data, during Q4, Bolt Biotherapeutics (NASDAQ:BOLT) posted sales of $1.41 million. Earnings were up…
Bolt Biotherapeutics Announces Topline Data From BDC-1001 Phase 1 Dose-Escalation Trial In HER2-Expressing Tumors, Supporting Advancement To Phase 2 Clinical Studies
BDC-1001 elicited objective clinical responses, including multiple PRs and long-term stable disease, across a diverse set of solid tumor types in monotherapy and in combination with nivolumab
Data support selection of
Benzinga Pro’s Top 5 Stocks To Watch For Tuesday, March 28, 2023: BABA, SQ, CRWD, GES, BOLT
Alibaba (BABA) - Shares were up 9% Tuesday morning following news the company will split into six business units. Expectations suggest one or several of the units could be the target of initial